Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity

August 2020 | 113 pages | ID: A33D5344B6F4EN
GMD Research

Abstracts

Asia Pacific oncology informatics market will grow by 7.8% annually with a total addressable market cap of $16.75 billion over 2020-2030 owing to the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.

Highlighted with 34 tables and 46 figures, this 113-page report “Asia Pacific Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Electronic Health Records (EHRs)
• Population Health Management (PHM)
• Clinical Decision Support System (CDSS)
• Drug Discovery and Development Informatics (DDDI)
• Data Analytics
• Image Analytics
• Other Product Types

Based on Cancer Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Medical Application
• Surgical Application
• Radiation Application

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Pharmaceutical Companies
• Life Science Companies
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
• Other End Users

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Electronic Health Records (EHRs)
3.3 Population Health Management (PHM)
3.4 Clinical Decision Support System (CDSS)
3.5 Drug Discovery and Development Informatics (DDDI)
3.6 Data Analytics
3.7 Image Analytics
3.8 Other Product Types

4 SEGMENTATION OF ASIA PACIFIC MARKET BY CANCER TYPE

4.1 Market Overview by Cancer Type
4.2 Colorectal Cancer
4.3 Breast Cancer
4.4 Prostate Cancer
4.5 Cervical Cancer

5 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Medical Application
5.3 Surgical Application
5.4 Radiation Application

6 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

6.1 Market Overview by End User
6.2 Pharmaceutical Companies
6.3 Life Science Companies
6.4 Contract Research Organizations (CROs)
6.5 Academic Institutes and Research Centers
6.6 Other End Users

7 ASIA-PACIFIC MARKET 2019-2030 BY COUNTRY

7.1 Overview of Asia-Pacific Market
7.2 Japan
7.3 China
7.4 Australia
7.5 India
7.6 South Korea
7.7 Rest of APAC Region

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc

9 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT

9.1 Risk Evaluation of Asia Pacific Market
9.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Asia Pacific Oncology Informatics Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Oncology Informatics Market
Table 3. Asia Pacific Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 4. Key Products and EHR Vendors
Table 5. Key Products and PHM Vendors
Table 6. Key Products and CDSS Vendors
Table 7. Key Products and DDDI Vendors
Table 8. Asia Pacific Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 9. Asia Pacific Oncology Informatics Market by Application, 2019-2030, $ mn
Table 10. Asia Pacific Oncology Informatics Market by End User, 2019-2030, $ mn
Table 11. APAC Oncology Informatics Market by Country, 2019-2030, $ mn
Table 12. Japan Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 13. Japan Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 14. Japan Oncology Informatics Market by End User, 2019-2030, $ mn
Table 15. China Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 16. China Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 17. China Oncology Informatics Market by End User, 2019-2030, $ mn
Table 18. Australia Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 19. Australia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 20. Australia Oncology Informatics Market by End User, 2019-2030, $ mn
Table 21. India Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 22. India Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 23. India Oncology Informatics Market by End User, 2019-2030, $ mn
Table 24. South Korea Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 25. South Korea Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 26. South Korea Oncology Informatics Market by End User, 2019-2030, $ mn
Table 27. Oncology Informatics Market in Rest of APAC by Country, 2019-2030, $ mn
Table 28. Cerner Corporation: Company Snapshot
Table 29. Cerner Corporation: Business Segmentation
Table 30. Cerner Corporation: Product Portfolio
Table 31. Cerner Corporation: Revenue, 2016-2018, $ mn
Table 32. Cerner Corporation: Recent Developments
Table 33. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 34. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Oncology Informatics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Oncology Informatics Market
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Oncology Informatics Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Oncology Informatics Market
Figure 11. Breakdown of Asia Pacific Oncology Informatics Market by Product Type, 2019-2030, % of Revenue
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)
Figure 13. Asia Pacific Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, $ mn
Figure 14. Asia Pacific Oncology Informatics Market: Population Health Management (PHM), 2019-2030, $ mn
Figure 15. Asia Pacific Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, $ mn
Figure 16. Asia Pacific Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, $ mn
Figure 17. Asia Pacific Oncology Informatics Market: Data Analytics, 2019-2030, $ mn
Figure 18. Asia Pacific Oncology Informatics Market: Image Analytics, 2019-2030, $ mn
Figure 19. Asia Pacific Oncology Informatics Market: Other Product Types, 2019-2030, $ mn
Figure 20. Breakdown of Asia Pacific Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue
Figure 21. Asia Pacific Addressable Market Cap in 2020-2030 by Cancer Type, Value ($ mn) and Share (%)
Figure 22. Asia Pacific Oncology Informatics Market: Colorectal Cancer, 2019-2030, $ mn
Figure 23. Asia Pacific Oncology Informatics Market: Breast Cancer, 2019-2030, $ mn
Figure 24. Asia Pacific Oncology Informatics Market: Prostate Cancer, 2019-2030, $ mn
Figure 25. Asia Pacific Oncology Informatics Market: Cervical Cancer, 2019-2030, $ mn
Figure 26. Breakdown of Asia Pacific Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue
Figure 27. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 28. Asia Pacific Oncology Informatics Market: Medical Application, 2019-2030, $ mn
Figure 29. Asia Pacific Oncology Informatics Market: Surgical Application, 2019-2030, $ mn
Figure 30. Asia Pacific Oncology Informatics Market: Radiation Application, 2019-2030, $ mn
Figure 31. Breakdown of Asia Pacific Oncology Informatics Market by End User, 2019-2030, % of Revenue
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 33. Asia Pacific Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, $ mn
Figure 34. Asia Pacific Oncology Informatics Market: Life Science Companies, 2019-2030, $ mn
Figure 35. Asia Pacific Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, $ mn
Figure 36. Asia Pacific Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, $ mn
Figure 37. Asia Pacific Oncology Informatics Market: Other End Users, 2019-2030, $ mn
Figure 38. Breakdown of APAC Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 39. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 40. Oncology Informatics Market in Japan, 2019-2030, $ mn
Figure 41. Oncology Informatics Market in China, 2019-2030, $ mn
Figure 42. Oncology Informatics Market in Australia, 2019-2030, $ mn
Figure 43. Oncology Informatics Market in India, 2019-2030, $ mn
Figure 44. Oncology Informatics Market in South Korea, 2019-2030, $ mn
Figure 45. Oncology Informatics Market in Rest of APAC, 2019-2030, $ mn
Figure 46. Growth Stage of Asia Pacific Oncology Informatics Industry over the Forecast Period


COMPANIES MENTIONED

Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc